Status:
TERMINATED
Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT
Lead Sponsor:
Turku University Hospital
Conditions:
Colorectal Cancer
Eligibility:
All Genders
40-80 years
Phase:
NA
Brief Summary
Measuring tumor response to treatment based on computed tomography (CT) and/or magnetic resonance imaging (MRI) has been a widely debated issue (response criteria in solid tumors \[RECIST\] and World ...
Eligibility Criteria
Inclusion
- Age 40 to 80 years old
- Language spoken: Finnish or Swedish
- Performance status: Karnofsky score 70 or better or WHO performance status 2 or better
- earlier diagnosed (histologically confirmed) colorectal cancer with discovered metastases at operation
- Earlier diagnosed and treated colorectal cancer with discovered recurrence in the follow up
- Mental status: Patients must be able to understand the meaning of the study
- Informed consent: The patient must sign the appropriate Ethical Committee (EC) approved informed consent documents in the presence of the designated staff
Exclusion
- Prior medical history: Patient must have no history of serious cardiovascular, liver or kidney disease
- Vulnerable study subjects such as described in Finnish law concerning clinical studies (disabled, children, pregnant or breast-feeding women, prisoners) will not be included.
Key Trial Info
Start Date :
December 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00823810
Start Date
December 1 2008
End Date
December 1 2011
Last Update
October 9 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Hospital
Turku, Finland, 20521